UV-C Sanitization Target healthcare and facility managers seeking device hygiene solutions for mobile devices, highlighting ALUVIS’s UV-C sanitization technology as a compact, easy-to-use solution with strong potential in clinics, hospitals, and care facilities.

Early Stage Growth With revenue under a million and a recent $650K funding round, identify growth-focused buyers in procurement and partnerships who value scalable, cost-efficient device sanitization tech to expand offerings without large capex.

SaaS-Adjacent Tech Stack Leverage the company’s digital presence and analytics stack (Webflow, Fullstory, Microsoft Clarity, Snowplow) to propose value-add tools such as usage analytics dashboards, onboarding optimization, and performance marketing collaborations for channel partners.

Strategic Partnerships Explore collaborations with large certification and testing firms (paralleling large peers in the sector) and distributors that can accelerate market entry, expand credibility, and co-market to healthcare facilities and enterprise IT teams.

Competitive Positioning Position ALUVIS as an entry-point, cost-conscious sanitization device for mobile endpoints, appealing to mid-sized clinics and long-tail healthcare providers who need rapid ROI and easy deployment compared to larger enterprise-grade safety solutions.